SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer, has promoted two in-house leaders to executive positions.
Badreddin Edris, who has been chief business officer, has been promoted to the chief operating officer role.
L. Mary Smith, previously the company’s senior vice president of clinical research and development, will now be its chief development officer.
L. Mary Smith
Saqib Islam, chief executive officer of the Stamford-based company, said they both have been critical to the company’s growth.
“I look forward to partnering with them and the rest of our experienced leadership team as we advance our ten clinical development programs for patients with severe rare diseases and cancer,” Islam said.
Edris joined SpringWorks in 2018, while Smith started when the company launched in 2017.
